BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Receivables

Track COSCIENS Biopharma's receivables ($2.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$2.78M
↑ 105.39% YoYΔ $1.43M vs prior year quarter

Peer trimmed avg / median

Loading

COSCIENS Biopharma Receivables History

Loading

COSCIENS Biopharma vs. peers: Receivables Comparison

Loading

COSCIENS Biopharma Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

COSCIENS Biopharma (CSCI) FAQ

COSCIENS Biopharma (CSCI) currently reports a receivables of $2.8M as of June 2025. That compares with $1.4M in the prior-year period — up 105.4% year over year. Use the charts on this page to explore COSCIENS Biopharma's receivables history and peer comparisons.

COSCIENS Biopharma's receivables increased from $1.4M to $2.8M — a 105.4% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

COSCIENS Biopharma reported $2.8M in receivables as of June 2025. That compares with $1.4M in the prior-year period — up 105.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $2.8M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for COSCIENS Biopharma, and consider following CSCI for alerts when major investors trade the stock.